FIRM
PHILOSOPHY
Investing in the biotechnology and healthcare sectors presents a compelling landscape characterized by both significant opportunities and risk. The aging global population, coupled with increasing awareness of chronic diseases and advancements in medical technology, fuels a consistent demand for innovative healthcare solutions. Biotechnology, in particular, stands at the forefront of groundbreaking discoveries, from gene editing and personalized medicine to rare drug therapies and diagnostics. This creates fertile ground to invest in companies developing transformative treatments and technologies that can address unmet medical needs and improve patient outcomes.
Copernicus is built on a strong culture of integrity, combined with intellectual rigor and curiosity, toward investment opportunities across all sectors of biotechnology & healthcare. Our strategy applies a disciplined and objective research process with the goal of generating superior absolute net returns to our investors. We run a concentrated public and private equity portfolio across the healthcare and life sciences universe of companies while concurrently deploying an active risk management strategy.
MANAGER
JOHN W. RENDE, FOUNDER/PORTFOLIO MANAGER
John founded Copernicus Capital Management, LLC in April 2013. Prior to Copernicus, John was the Senior Portfolio Manager responsible for the $400M healthcare portfolio at Weintraub Capital Management, LLC, a multi-strategy investment firm based in San Francisco which converted to a family office in December 2012. At Weintraub, John produced positive returns in twelve out of thirteen years, including the more challenging years of 2008 and 2002.
Prior to Weintraub, John worked at Wells Fargo as a credit and fixed income analyst and as a Portfolio Manager in their Asset Management Group. John also worked at Cowen & Company in their Healthcare Investment Banking unit during business school at UCLA. John began his career in healthcare at American Bionetics, a biotechnology firm specializing in the research and design of HIV confirmatory tests.
John served six years as a board member of the San Francisco General Hospital Foundation and currently serves on the board of the Price Center at UCLA. John received his MBA from the John E. Anderson Graduate School of Management at UCLA, and has a joint degree, magna cum laude, in Biology and Economics from Claremont McKenna College. While at Claremont, John was a three time All-American and Scholar Athlete in tennis.
CONTACT
US
Copernicus Capital Management, LLC
2055 Lombard Street
San Francisco, CA 94123
415-602-4087